A carregar...
Pyrotinib enhances the radiosensitivity of HER2-overexpressing gastric and breast cancer cells
The overexpression or amplification of HER2 has been observed in a significant proportion of both gastric cancer (GC) and breast cancer (BC) cases. Pyrotinib is an irreversible dual (EGFR/HER2) tyrosine kinase inhibitor (TKI), newly evaluated for the treatment of HER2-overexpressing cancer types. As...
Na minha lista:
| Publicado no: | Oncol Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7640366/ https://ncbi.nlm.nih.gov/pubmed/33125154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2020.7820 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|